tetano
Editor, Senior Moderator
J Emerg Med
. 2021 Oct 23;S0736-4679(21)00745-9.
doi: 10.1016/j.jemermed.2021.10.008. Online ahead of print.
Cardiac Tamponade After COVID-19 Vaccination
Adam T Hryniewicki[SUP] 1 [/SUP], Vaishal M Tolia[SUP] 1 [/SUP], Rahul V Nene[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Acute pericarditis is a diffuse inflammation of the pericardial sac with many well-defined etiologies. Acute pericarditis as a vaccine-related adverse event is a rare entity, and the association between pericarditis and the immunogenic response to Coronavirus disease 2019 (COVID-19) vaccines is still being fully characterized.
Case report: A previously healthy 18-year-old man presented with fever, pleuritic chest pain, and shortness of breath 3 weeks after receiving the first dose of a COVID-19 mRNA-based vaccine. The patient was found to have a large pericardial effusion with early tamponade physiology requiring pericardiocentesis. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: As COVID-19 vaccination becomes more prevalent globally, physicians should be aware of pericarditis as a rare but potentially serious adverse reaction. Although a direct causal link cannot be demonstrated, we present this case to increase awareness among emergency physicians of pericarditis as a rare, but potentially serious adverse event associated with COVID-19 vaccination.
Keywords: COVID-19 vaccine; pericarditis; vaccine-related adverse event.
. 2021 Oct 23;S0736-4679(21)00745-9.
doi: 10.1016/j.jemermed.2021.10.008. Online ahead of print.
Cardiac Tamponade After COVID-19 Vaccination
Adam T Hryniewicki[SUP] 1 [/SUP], Vaishal M Tolia[SUP] 1 [/SUP], Rahul V Nene[SUP] 1 [/SUP]
Affiliations
- PMID: 34996671
- DOI: 10.1016/j.jemermed.2021.10.008
Abstract
Background: Acute pericarditis is a diffuse inflammation of the pericardial sac with many well-defined etiologies. Acute pericarditis as a vaccine-related adverse event is a rare entity, and the association between pericarditis and the immunogenic response to Coronavirus disease 2019 (COVID-19) vaccines is still being fully characterized.
Case report: A previously healthy 18-year-old man presented with fever, pleuritic chest pain, and shortness of breath 3 weeks after receiving the first dose of a COVID-19 mRNA-based vaccine. The patient was found to have a large pericardial effusion with early tamponade physiology requiring pericardiocentesis. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: As COVID-19 vaccination becomes more prevalent globally, physicians should be aware of pericarditis as a rare but potentially serious adverse reaction. Although a direct causal link cannot be demonstrated, we present this case to increase awareness among emergency physicians of pericarditis as a rare, but potentially serious adverse event associated with COVID-19 vaccination.
Keywords: COVID-19 vaccine; pericarditis; vaccine-related adverse event.